Outlining the investment case for Chemours Co (NYSE: CC), JPMorgan said the company has a proprietary set of very profitable newer generation refrigerants, with patent lives extending to 2022, wit
Latest Ratings for CC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 2017 | JP Morgan | Upgrades | Neutral | Overweight |
| Mar 2017 | Jefferies | Upgrades | Hold | Buy |
| Feb 2017 | Susquehanna | Upgrades | Neutral | Positive |
View More Analyst Ratings for CC
View the Latest Analyst Ratings
May 12, 2017 at 08:00PM
from Shanthi Rexaline
No comments:
Post a Comment